Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001615774-17-004132
Filing Date
2017-08-08
Accepted
2017-08-08 06:18:41
Documents
8
Period of Report
2017-08-08

Document Format Files

Seq Description Document Type Size
1 6-K s107080_6k.htm 6-K 20056
2 EXHIBIT 99.1 s107080_ex99-1.htm EX-99.1 38230
3 EXHIBIT 99. s107080_ex99-2.htm EX-99.2 22958
4 GRAPHIC img004_v1.jpg GRAPHIC 2309
5 GRAPHIC img005_v1.jpg GRAPHIC 1947
6 GRAPHIC img001_v1.jpg GRAPHIC 9026
7 GRAPHIC img002_v1.jpg GRAPHIC 22965
8 GRAPHIC img003_v1.jpg GRAPHIC 6172
  Complete submission text file 0001615774-17-004132.txt   141272
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 171013158
SIC: 2834 Pharmaceutical Preparations